Sensitivity and Validity of Three Bronchial Provocation Tests to Demonstrate the Effect of Inhaled Corticosteroids in Asthma

Chest

Volumn 124, Issue 4, 2003, Pages 1341-1349

  Koskela, Heikki O ^a   Hyvärinen, Liisa ^a   Brannan, John D ^b   Chan, Hak Kim ^c   Anderson, Sandra D ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asthma; Asthma treatment; Bronchial hyperresponsiveness; Bronchial provocation; Cold air; Histamine; Mannitol

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; HISTAMINE; MANNITOL;

ACCURACY; ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; COLD AIR; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PEAK EXPIRATORY FLOW; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

EID: 10744233004     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.4.1341     Document Type: Article

References (25)

1. Bousquet J, Jeffery PK, Busse WW, et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161:1720-1745
2. National Heart Lung and Blood Institute. Global initiative for asthma: global strategy for asthma management and prevention; NHLBI/WHO workshop report. Bethesda, MD: National Heart Lung and Blood Institute, 1995; publication No. 95-3659
3. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyper-responsiveness as an additional guide to long-term treatment; the AMPUL Study Group. Am J Respir Crit Care Med 1999; 159:1043-1051
4. Ward C, Pais M, Bish R, et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57:309-316
5. O'Connor BJ, Ridge SM, Barnes PJ, et al. Greater effect of inhaled budesonide on adenosine 5′-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma. Am Rev Respir Dis 1992; 146:560-564
6. Doull IJ, Sandall D, Smith S, et al. Differential inhibitory effect of regular inhaled corticosteroid on airway responsiveness to adenosine 5′ monophosphate, methacholine, and bradykinin in symptomatic children with recurrent wheeze. Pediatr Pulmonol 1997; 23:404-411
7. Weersink EJ, Douma RR, Postma DS, et al. Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma. Am J Respir Crit Care Med 1997; 155:1241-1246
8. Meijer RJ, Kerstjens HA, Arends LR, et al. Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax 1999; 54: 894-899
9. Nielsen KG, Bisgaard H. The effect of inhaled budesonide on symptoms, lung function, and cold air and methacholine responsiveness in 2- to 5-year-old asthmatic children. Am J Respir Crit Care Med 2000; 162:1500-1506
10. Reynolds CJ, Togias A, Proud D. Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone. Clin Exp Allergy 2002; 32:1174-1179
11. Fuller RW, Choudry NB, Eriksson G. Action of budesonide on asthmatic bronchial hyperresponsiveness: effects on directly and indirectly acting bronchoconstrictors. Chest 1991; 100:670-674
12. Vathenen AS, Knox AJ, Wisniewski A, et al. Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air in patients with asthma. Thorax 1991; 46:811-816
13. Rodwell LT, Anderson SD, Seale JP. Inhaled steroids modify bronchial responses to hyperosmolar saline. Eur Respir J 1992; 5:953-962
14. du Toit JI, Anderson SD, Jenkins CR, et al. Airway responsiveness in asthma: bronchial challenge with histamine and 4.5% sodium chloride before and after budesonide. Allergy Asthma Proc 1997; 18:7-14
15. Brannan JD, Koskela H, Anderson SD, et al. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002; 7:37-44
16. Petitti DB. Epidemiologic issues in outcomes research. In: Brownson RC, Petitti DB, eds. Applied epidemiology. 1st ed. New York, NY: Oxford University Press, 1998; 249-275
17. Peittola S, Ruponen M. Pharmaca Fennica. Rauma, Finland: Lääketietokeskus, 2002; 2408
18. Viljanen AA, Halttunen PK, Kreus K-E, et al. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest 1982; 42:5-20
19. Viljanen AA, Viljanen BC, Halttunen PK, et al. Pulmonary diffusing capacity and volumes in healthy adults measured with the single breath technique. Scand J Clin Lab Invest 1982; 42:21-34
20. American Thoracic Society. Standardization of spirometry-1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
21. Higgins BG, Britton JR, Chinn S, et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989; 140:1368-372
22. Anderson SD, Brannan J, Spring J, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156:758-765
23. Sovijarvi AR, Malmberg LP, Reinikainen K, et al. A rapid dosimetric method with controlled tidal breathing for histamine challenge: repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993; 104:164-170
24. Koskela HO, Räsänen SH, Tukiainen HO. The diagnostic value of cold air hyperventilation in adults with suspected asthma. Respir Med 1997; 91:470-478
25. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163:406-412